Manages pain severe enough to require an opioid analgesic. ANDA 205814, held by Aurolife Pharma. Hydromorphone Hydrochloride.
As of Nov 18, 2026, ANDA 205814 (Hydromorphone Hydrochloride), held by Aurolife Pharma, was first approved by FDA on May 13, 2016, with 6 approved supplements and 0 published complete response letters.
Hydromorphone Hydrochloride Tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, reserve Hydromorphone Hydrochloride Tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or opioid combination products]: Have not been tolerated, or are not expected to be tolerated, Have not provided adequate analgesia, or are not expected to provide adequate analgesia
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 13, 2016 | Original application | Approved |
| Hydromorphone Hydrochloride2MG ยท tablet;oral | Hydromorphone Hydrochloride | Rx |
| Hydromorphone Hydrochloride4MG ยท tablet;oral | Hydromorphone Hydrochloride | Rx |
| Hydromorphone Hydrochloride8MG ยท tablet;oral | Hydromorphone Hydrochloride | Rx |
| Jun 18, 2026 | Supplement 7REMS | Approved | None posted |
| Oct 31, 2024 | Supplement 6REMS | Approved | None posted |
| Apr 7, 2020 | Supplement 1Labeling ยท Standard review | Approved | None posted |
| Apr 7, 2020 | Supplement 3Labeling ยท Standard review | Approved | None posted |
| Apr 7, 2020 | Supplement 4Labeling ยท Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 2REMS | Approved | None posted |
| May 13, 2016 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. โWhat FDA's review saysโ is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters